Search: influenza+a+h1n1+pathophysiology

Sponsored Links


WHO Pharmacological Guideline in the Management of Pandemic (H1N1) 2009 Influenza

Below we provide you with informations regarding basis for advice to physicians/clinicians on the use of antivirals for patients performing with illness due to influenza virus infection such as oseltamivir and zanamivir (neuraminidase inhibitors) and M2 inhibitors (amantadine and rimantadine) which is issued by the World Health Organization. This pharmacological guideline for pandemic H1N1 Influenza includes recommendations on the use of some o…

Category: Swine Flu | Tags: , , , | 4:35 pm | comments 0 Comments

Healthcare Provider Guidelines for the Use of Peramivir IV to Treat 2009 H1N1 Influenza

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for an experimental new drug called peramivir, made by Biocryst Pharmaceuticals Inc and licensed to Shionogi & Co Ltd as Reuter stated. And this is a guideline about the use of Peramivir IV under Emergency Use Authorization for Health Care Providers in treating 2009 H1N1 Influenza. The article provides brief explanation regarding the use of this neuroaminidase…

Category: Physician Guidelines | Tags: , , , | 10:20 am | comments 0 Comments